Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
Condition(s):COVID-19 Acute Respiratory Distress SyndromeLast Updated:April 15, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19 Acute Respiratory Distress SyndromeLast Updated:April 15, 2022Recruiting
Condition(s):ARDS, HumanLast Updated:February 20, 2024Recruiting
Condition(s):Mechanical Ventilation; Artificial RespirationLast Updated:February 28, 2024Not yet recruiting
Condition(s):ARDSLast Updated:January 9, 2024Completed
Condition(s):Respiratory Failure; Acute Respiratory Distress Syndrome; Ventilator LungLast Updated:April 23, 2021Completed
Condition(s):Cardiac Surgical Procedures; Continuous Positive Airway Pressure; BIPAP Biphasic Intermittent Positive Airway PressureLast Updated:July 28, 2023Recruiting
Condition(s):Mechanical Ventilation ComplicationLast Updated:October 13, 2022Recruiting
Condition(s):COPD; OSALast Updated:August 18, 2016Completed
Condition(s):Mechanical Ventilation Complication; Weaning Failure; Airway ObstructionLast Updated:March 26, 2024Completed
Condition(s):Acute Respiratory Distress SyndromeLast Updated:March 19, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.